Search results for "Germany"

showing 10 items of 1172 documents

ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.

2015

Malemedicine.medical_specialtyActivities of daily livingTime FactorsUrticariaMEDLINEDermatologyUnmet needsGermanLife Change Events030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Cost of IllnessGermanySurveys and QuestionnairesActivities of Daily LivingmedicineHumansAge of OnsetPsychiatryChronic urticariaInternetbusiness.industryPatient Acceptance of Health Carelanguage.human_languageClinical Practice030228 respiratory systemFamily medicineChronic DiseaselanguageQuality of LifeFemaleAge of onsetbusinessThe British journal of dermatology
researchProduct

Gender Differences in Patients Admitted to a Certified German Chest Pain Unit: Results from the German Chest Pain Unit Registry.

2020

<b><i>Introduction:</i></b> Gender-specific atypical clinical presentation in acute coronary syndrome and sex-specific outcomes in cardiovascular disease in women are well known. The aim of this study is to analyze possible differences between men and women presenting to certified German chest pain units (CPUs). <b><i>Methods:</i></b> Data from 13,900 patients derived from the German CPU registry were analyzed for gender differences in patient characteristics, cardiovascular disease manifestation, critical time intervals, treatment and prognosis. <b><i>Results:</i></b> A total of 37.8% of patients were female. Typical c…

Malemedicine.medical_specialtyAcute coronary syndromeChest PainMyocardial ischemiaMedizinDiseaseChest painGermanPatient AdmissionSex FactorsRisk FactorsInternal medicineGermanymedicineHumansPharmacology (medical)In patientRegistriesMedical diagnosisAcute Coronary SyndromeSex DistributionAgedAged 80 and overbusiness.industryMiddle Agedmedicine.diseaselanguage.human_languagelanguageFemalemedicine.symptomPresentation (obstetrics)Cardiology and Cardiovascular MedicinebusinessCardiology
researchProduct

Timing of percutaneous coronary intervention in troponin-negative patients with acute coronary syndrome without persistent ST-segment elevation: prel…

2015

OBJECTIVE Management of acute coronary syndromes without persistent ST-segment elevation (NSTE-ACS) and unstable angina pectoris (UAP) remains challenging. The study aimed to analyze the current management of UAP patients in German chest pain units focussing on the different time lines of invasive strategy. METHODS A total of 1400 UAP patients admitted to a certified chest pain unit were enrolled. Analyses of high-risk criteria with indication for invasive management and of 3-month clinical outcomes were performed by subgrouping UAP patients to immediate and early invasive (<8 hours), early elective invasive (8-24 hours), late elective invasive (24-72 hours) strategy, and without percutaneo…

Malemedicine.medical_specialtyAcute coronary syndromeChest PainTime Factorsmedicine.medical_treatmentOperative TimeChest painCoronary AngiographyElectrocardiographyPatient AdmissionPercutaneous Coronary InterventionInternal medicineGermanyMedicineST segmentHumansRegistriesAcute Coronary SyndromeAgedRetrospective Studiesbusiness.industryUnstable anginaCoronary Care UnitsPercutaneous coronary interventionRetrospective cohort studyMiddle Agedmedicine.diseaseTroponinRegimenTreatment OutcomeConventional PCICardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesCritical pathways in cardiology
researchProduct

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the A…

2007

Summary. Background: Tissue factor (TF) and its specific inhibitor, tissue factor pathway inhibitor (TFPI), are important contributors to the initiation of the coagulation process. Objectives: To compare plasma levels of soluble TF (sTF) and free-TFPI (f-TFPI) between patients with stable angina pectoris (SAP) and acute coronary syndrome (ACS) and to assess the impact of the two variables on long-term prognosis. Patients/methods: Patients with SAPs (n = 1146) and acute coronary syndrome (n = 523) from the AtheroGene study were included and followed for 2.3 years. Because of the strong impact of unfractionated heparin (UFH) on f-TFPI levels, but not on sTF levels, patients having received UF…

Malemedicine.medical_specialtyAcute coronary syndromeTime FactorsLipoproteinsMyocardial InfarctionRisk AssessmentSeverity of Illness IndexAngina PectorisThromboplastinCoronary artery diseaseCohort StudiesTissue factor pathway inhibitorPredictive Value of TestsInternal medicineGermanymedicineHumansMyocardial infarctionProspective StudiesAgedProportional Hazards ModelsUnstable anginabusiness.industryHazard ratioCoronary StenosisHematologySyndromeMiddle Agedmedicine.diseasePrognosisThrombosisCardiovascular DiseasesCardiologyFemalebusinessBiomarkersBlood drawingFollow-Up StudiesJournal of thrombosis and haemostasis : JTH
researchProduct

Randomized response estimates for doping and illicit drug use in elite athletes.

2008

Abstract Background To date, there are estimates for the percentage of unknown cases of doping and illicit drug use in fitness sports, but not for elite sports. This can be attributed to the problem of implementing questionnaires and surveys to get reliable epidemiological estimates of deviant or illicit behaviour. Methods All athletes questioned were subject to doping controls as members or junior members of the national teams. In order to estimate the prevalence of doping and illicit drug abuse, the athletes were either issued an anonymous standardized questionnaire (SQ; n  = 1394) or were interviewed using randomized response technique (RRT; n  = 480). We used a two-sided z -test to comp…

Malemedicine.medical_specialtyAdolescentSubstance-Related DisordersToxicologyGermanySurveys and QuestionnairesEpidemiologymedicineRandomized responsePrevalenceIllicit drugHumansPharmacology (medical)Elite athletesPsychiatryPharmacologyDoping in Sportsbiologybusiness.industryAthletesRandomized Response Techniquetechnology industry and agriculturemedicine.diseasebiology.organism_classificationTest (assessment)Substance abusePsychiatry and Mental healthFemalebusinesshuman activitiesDemographyDrug and alcohol dependence
researchProduct

Laparoscopy for Abdominal Testes: Nationwide Analysis of German Routine Data

2021

Introduction: Laparoscopy has been used for the evaluation of impalpable testes for more than 30 years. However, its use for intra-abdominal testes has never been evaluated in a population-based ap...

Malemedicine.medical_specialtyAdolescentmedicine.medical_treatmentPopulationPopulation basedMedical RecordsGerman03 medical and health sciences0302 clinical medicineGermanyCryptorchidismHumansMedicineOrchiopexyChildeducationLaparoscopyeducation.field_of_studymedicine.diagnostic_testbusiness.industryGeneral surgeryHealth services researchInfantlanguage.human_languageSurgeryTreatment OutcomeChild PreschoolOrchiopexy030220 oncology & carcinogenesislanguageLaparoscopy030211 gastroenterology & hepatologySurgerybusinessJournal of Laparoendoscopic &amp; Advanced Surgical Techniques
researchProduct

Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously

2009

Kamin W, Kopp MV, Erdnuess F, Schauer U, Zielen S, Wahn U. Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. Pediatr Allergy Immunol 2010: 21: e160–e165. © 2009 John Wiley & Sons A/S Introduction  Seasonal allergic rhinitis (SAR) affects at least 10–25% of the Caucasian race and about 40% of patients are children. Standard treatment of SAR is specific immunotherapy (SIT), but anti-allergic drugs can significantly enhance efficacy of SIT. One candidate is the humanized monoclonal anti-IgE antibody omalizumab. Material and Methods  Randomized, double-blind, placebo-controlled, multi-centre trial in German…

Malemedicine.medical_specialtyAllergyAdolescentImmunologyOmalizumabOmalizumabAntibodies Monoclonal HumanizedPoaceaePlacebolaw.inventionRandomized controlled triallawGermanyInternal medicinemedicineHumansImmunology and AllergyChildAdverse effectAsthmabusiness.industryStandard treatmentAntibodies MonoclonalRhinitis Allergic SeasonalAllergensImmunoglobulin Emedicine.diseaseAntibodies Anti-IdiotypicSurgeryTolerabilityPediatrics Perinatology and Child HealthFeasibility StudiesPollenDrug Therapy CombinationFemaleImmunotherapybusinessmedicine.drugPediatric Allergy and Immunology
researchProduct

Venous thromboembolism in patients hospitalized for hip joint replacement surgery

2020

Venous thromboembolism (VTE) is a potentially life-threatening disease. Major transient risk factors include trauma, surgery, and immobilization. Patients undergoing hip joint replacement (HJR) are characterized by a high risk of postoperative VTE, but data on the time trends of VTE rates in this population are sparse.In an analysis of the German nationwide inpatient sample, we included all hospitalizations for elective primary HJR in Germany from 2005 to 2016. Time trends of the surgical procedure, overall death rates, and VTE rates were analysed, and predictors of VTE identified.Overall, 1,885,839 inpatients with elective primary HJR (59.1% women, 51.4% ≥70 years) were included in the ana…

Malemedicine.medical_specialtyArthroplasty Replacement HipPopulation2720 Hematology610 Medicine & healthDisease030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsHip replacementGermanymedicineHumanscardiovascular diseasesHospital Mortalityeducationeducation.field_of_studybusiness.industryMortality rate10031 Clinic for AngiologyCancerPerioperativeVenous ThromboembolismHematologyequipment and suppliesmedicine.diseaseSurgeryPulmonary embolismHospitalization030220 oncology & carcinogenesisFemalebusinessVenous thromboembolism
researchProduct

Accordance of Online Health Information on Prostate Cancer with the European Association of Urology Guidelines.

2017

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; The internet is an emerging source of information for prostate cancer (PCa) patients. Since little is known about the quality of information on PCa provided online, we investigated its accordance to the latest European Association of Urology (EAU) guidelines. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; A total of 89 German web pages were included for analysis. A quality model classifying the provider of information and its expertise was introduced. Correctness of provided information was systematically compared to the EAU guidelines. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; Information was provided by medical experts (41%), media (1…

Malemedicine.medical_specialtyAssociation (object-oriented programming)Urology030232 urology & nephrologyurologic and male genital diseasesAccess to Information03 medical and health sciencesProstate cancer0302 clinical medicinePatient Education as TopicGermanymedicineHumansSocieties MedicalInternetbusiness.industryInformation seekingInformation qualityProstatic Neoplasmsmedicine.diseaseInformation behaviorEuropeAccess to information030220 oncology & carcinogenesisFamily medicinePractice Guidelines as TopicThe InternetHealth informationNeoplasm Recurrence LocalbusinessUrologia internationalis
researchProduct

Midterm follow-up after DC-BEAD™-TACE of Hepatocellular Carcinoma (HCC)

2012

Abstract Aim To determine local response, its predictors and survival and complication rates after DC-Bead™-TACE in patients with hepatocellular carcinoma (HCC). Materials and methods DC-Beads™ are non-resorbable, polyvinyl-alcoholic hydrophilic microspheres. They release high amounts of chemotherapeutics directly into the tumour. Delivery is sustained over time, tumour feeders are embolised. We used beads from 100–300 to 500–700 μm loaded with Doxorubicin (max. 150 mg/4 ml). Fifty patients (mean age: 68.5 ± 8.8 years) with HCC were analysed. DC-Bead™-TACE was performed once or repeated in two-month intervals. Imaging scans (CT or MRI) were done one-month following each procedure. To evalua…

Malemedicine.medical_specialtyCarcinoma HepatocellularPleural effusionAntineoplastic AgentsComorbidityGastroenterologyRisk FactorsGermanyInternal medicinePrevalencemedicineCarcinomaHumansRadiology Nuclear Medicine and imagingChemoembolization TherapeuticSurvival rateSurvival analysisAgedUltrasonographybusiness.industryLiver NeoplasmsGeneral Medicinemedicine.diseaseSurvival AnalysisSurgerySurvival RateTreatment OutcomeDoxorubicinDelayed-Action PreparationsHepatocellular carcinomaFemaleLiver functionbusinessProgressive diseaseFollow-Up StudiesLiver abscessEuropean Journal of Radiology
researchProduct